No Data
No Data
Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday
JMP Securities Maintains Bicycle Therapeutics(BCYC.US) With Buy Rating, Cuts Target Price to $26
Analysts Offer Insights on Healthcare Companies: Century Therapeutics (IPSC), Incyte (INCY) and Bicycle Therapeutics (BCYC)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Zoetis (ZTS), Walgreens Boots Alliance (WBA) and Bicycle Therapeutics (BCYC)
Bicycle Therapeutics(BCYC.US) 10% Shareholder Buys US$21.23 Million in Common Stock
Baker Bros. Advisors Increases Stake in Bicycle Therapeutics With $21.2 Million Purchase